Terms: = Leukemia AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Diagnosis
50 results:
1. Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms.
Puzo CJ; Tormey CA; Rinder HM; Siddon AJ
Transplant Cell Ther; 2023 Jul; 29(7):459.e1-459.e4. PubMed ID: 37062510
[TBL] [Abstract] [Full Text] [Related]
2. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract] [Full Text] [Related]
3. Clinico-laboratory pertinences and management of relapsed and refractory.
Musteata V
J BUON; 2021; 26(3):1165-1168. PubMed ID: 34268985
[TBL] [Abstract] [Full Text] [Related]
4. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
Jalal SD
PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
[TBL] [Abstract] [Full Text] [Related]
5. diagnosis of hairy cell leukaemia by fine needle aspiration cytology of lymph node.
Suneel R; Rajasekaran S; Kaur H; Mallik N; Garg D; Jain A; Dey P
Diagn Cytopathol; 2021 Apr; 49(4):E167-E171. PubMed ID: 33002340
[TBL] [Abstract] [Full Text] [Related]
6. On point in primary CNS lymphoma.
Tsang M; Cleveland J; Rubenstein JL
Hematol Oncol; 2020 Dec; 38(5):640-647. PubMed ID: 32510610
[TBL] [Abstract] [Full Text] [Related]
7. Which Markers Should the used for Diagnostic Chronic Lymphocytic leukemia Immunophenotyping Scoring System by Flow Cytometry?
Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Flow-Cytometric Testing in Chronic Lymphocytic leukemia.
Salem DA; Stetler-Stevenson M
Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
[TBL] [Abstract] [Full Text] [Related]
9. Multi-study reanalysis of 2,213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures.
Roushangar R; Mias GI
Sci Rep; 2019 Aug; 9(1):12413. PubMed ID: 31455838
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Chronic Hematologic Malignancies on In-Hospital Outcomes of Patients With ST-Segment Elevation Myocardial Infarction.
Patel G; Pancholy N; Thomas L; Rai A; Kher A; Peters C; Amin A; Patel TM; Pancholy S
Am J Cardiol; 2019 Aug; 124(3):349-354. PubMed ID: 31196560
[TBL] [Abstract] [Full Text] [Related]
11. Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.
Autore F; Strati P; Laurenti L; Ferrajoli A
Haematologica; 2018 Jun; 103(6):931-938. PubMed ID: 29748447
[TBL] [Abstract] [Full Text] [Related]
12. Usefulness of the CLLflow score.
Sorigue M; Franch-Sarto M; Sarrate E; Junca J
Cytometry B Clin Cytom; 2018 Nov; 94(6):950-952. PubMed ID: 29316199
[TBL] [Abstract] [Full Text] [Related]
13. Immunophenotyping of Chronic Lymphocytic leukemia.
Falay M; Özet G
Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
[TBL] [Abstract] [Full Text] [Related]
14. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
Rawstron AC; Kreuzer KA; Soosapilla A; Spacek M; Stehlikova O; Gambell P; McIver-Brown N; Villamor N; Psarra K; Arroz M; Milani R; de la Serna J; Cedena MT; Jaksic O; Nomdedeu J; Moreno C; Rigolin GM; Cuneo A; Johansen P; Johnsen HE; Rosenquist R; Niemann CU; Kern W; Westerman D; Trneny M; Mulligan S; Doubek M; Pospisilova S; Hillmen P; Oscier D; Hallek M; Ghia P; Montserrat E
Cytometry B Clin Cytom; 2018 Jan; 94(1):121-128. PubMed ID: 29024461
[TBL] [Abstract] [Full Text] [Related]
15. diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
[TBL] [Abstract] [Full Text] [Related]
16. The Role of CD200 and CD43 Expression in Differential diagnosis between Chronic Lymphocytic leukemia and Mantle Cell Lymphoma.
Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
[TBL] [Abstract] [Full Text] [Related]
17. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Sun Y; Wang SA; Sun T
Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
[TBL] [Abstract] [Full Text] [Related]
18. Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia.
Sekiya Y; Xu Y; Muramatsu H; Okuno Y; Narita A; Suzuki K; Wang X; Kawashima N; Sakaguchi H; Yoshida N; Hama A; Takahashi Y; Kato K; Kojima S
Br J Haematol; 2017 Jan; 176(2):248-257. PubMed ID: 27861730
[TBL] [Abstract] [Full Text] [Related]
19. Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina.
Freeman AT; Meyer AM; Smitherman AB; Zhou L; Basch EM; Shea TC; Wood WA
Cancer; 2016 Oct; 122(19):3041-50. PubMed ID: 27351768
[TBL] [Abstract] [Full Text] [Related]
20. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients.
Geyer JT; Subramaniyam S; Jiang Y; Elemento O; Ferry JA; de Leval L; Nakashima MO; Liu YC; Martin P; Mathew S; Orazi A; Tam W
Hum Pathol; 2015 Feb; 46(2):260-71. PubMed ID: 25529125
[TBL] [Abstract] [Full Text] [Related]
[Next]